STM-434
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STM-434, covering 2017-02-13 to 2017-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]